Oligometastatic prostate cancer (OMPC) is typically treated with systemic therapy, which may be complemented by radiotherapy (RT) of the prostate as part of primary directed therapy (PDT). This study retrospectively evaluated clinical outcomes following PDT in OMPC. Twenty-four consecutive patients who underwent PDT for OMPC between 2011 and 2023 were analyzed retrospectively.
Minglun Li
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Minglun
Contact Minglun, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack